Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use

Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use

US Patent 10072003 · Granted Sep 11, 2018

Estimated economic value: $76,678,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors2025
Factor XI activation inhibitors2025
Small molecule inhibitors of KRAS G12C mutant2025
Small molecule inhibitors of KRAS G12C mutant2025
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) in2025
Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhi2025
Aryl sulfonamides as BLT1 antagonists2025
GPR40 agonists2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025